Literature DB >> 18486283

Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection.

Ruth H Florese1, Roger W Wiseman, David Venzon, Julie A Karl, Thorsten Demberg, Kay Larsen, Leon Flanary, V S Kalyanaraman, Ranajit Pal, Fausto Titti, L Jean Patterson, Megan J Heath, David H O'Connor, Aurelio Cafaro, Barbara Ensoli, Marjorie Robert-Guroff.   

Abstract

Protection afforded by HIV Tat-based vaccines has differed in Indian rhesus and Mauritian cynomolgus macaques. We evaluated native Tat and Ad-HIVtat priming/Tat-boosting regimens in both species. Both vaccines were immunogenic. Only the Ad-tat regimen modestly reduced acute viremia in rhesus macaques after SHIV(89.6P) challenge. Confounding variables uncovered in Mauritian macaques included significant associations of susceptibility to infection with MHC class IB and class II H2 and H5 haplotypes, and resistance to infection with class IB haplotypes H3 and H6. Although protection here was limited, Tat-based vaccines incorporating other HIV components have shown greater efficacy. Combination strategies should be further explored.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486283      PMCID: PMC2577850          DOI: 10.1016/j.vaccine.2008.03.100

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  64 in total

1.  An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains.

Authors:  V Raúl Gómez-Román; Ruth H Florese; Bo Peng; David C Montefiori; Vaniambadi S Kalyanaraman; David Venzon; Indresh Srivastava; Susan W Barnett; Marjorie Robert-Guroff
Journal:  J Acquir Immune Defic Syndr       Date:  2006-11-01       Impact factor: 3.731

2.  Simian immunodeficiency virus SIVmac239 infection of major histocompatibility complex-identical cynomolgus macaques from Mauritius.

Authors:  Roger W Wiseman; Jason A Wojcechowskyj; Justin M Greene; Alex J Blasky; Tobias Gopon; Taeko Soma; Thomas C Friedrich; Shelby L O'Connor; David H O'Connor
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

3.  A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.

Authors:  Thorsten Demberg; Ruth H Florese; Megan J Heath; Kay Larsen; Irene Kalisz; V S Kalyanaraman; Eun Mi Lee; Ranajit Pal; David Venzon; Richard Grant; L Jean Patterson; Birgit Korioth-Schmitz; Adam Buzby; Dilani Dombagoda; David C Montefiori; Norman L Letvin; Aurelio Cafaro; Barbara Ensoli; Marjorie Robert-Guroff
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

4.  Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses.

Authors:  Nina V Malkevitch; L Jean Patterson; M Kristine Aldrich; Yichen Wu; David Venzon; Ruth H Florese; V S Kalyanaraman; Ranajit Pal; Eun Mi Lee; Jun Zhao; Anthony Cristillo; Marjorie Robert-Guroff
Journal:  Virology       Date:  2006-06-30       Impact factor: 3.616

5.  Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology.

Authors:  J W Romano; R N Shurtliff; E Dobratz; A Gibson; K Hickman; P D Markham; R Pal
Journal:  J Virol Methods       Date:  2000-04       Impact factor: 2.014

6.  Minimization of chronic plasma viremia in rhesus macaques immunized with synthetic HIV-1 Tat peptides and infected with a chimeric simian/human immunodeficiency virus (SHIV33).

Authors:  G Goldstein; K Manson; G Tribbick; R Smith
Journal:  Vaccine       Date:  2000-06-15       Impact factor: 3.641

7.  Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands.

Authors:  Wim Jennes; Sonja Verheyden; Christian Demanet; Christiane A Adjé-Touré; Bea Vuylsteke; John N Nkengasong; Luc Kestens
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

8.  Control of simian immunodeficiency virus SIVmac239 is not predicted by inheritance of Mamu-B*17-containing haplotypes.

Authors:  Jason A Wojcechowskyj; Levi J Yant; Roger W Wiseman; Shelby L O'Connor; David H O'Connor
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

9.  Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques.

Authors:  C D Pauza; P Trivedi; M Wallace; T J Ruckwardt; H Le Buanec; W Lu; B Bizzini; A Burny; D Zagury; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  KIR/HLA pleiotropism: protection against both HIV and opportunistic infections.

Authors:  Ying Qi; Maureen P Martin; Xiaojiang Gao; Lisa Jacobson; James J Goedert; Susan Buchbinder; Gregory D Kirk; Stephen J O'Brien; John Trowsdale; Mary Carrington
Journal:  PLoS Pathog       Date:  2006-08       Impact factor: 6.823

View more
  27 in total

1.  Mauritian cynomolgus macaques share two exceptionally common major histocompatibility complex class I alleles that restrict simian immunodeficiency virus-specific CD8+ T cells.

Authors:  Benjamin J Burwitz; Chad J Pendley; Justin M Greene; Ann M Detmer; Jennifer J Lhost; Julie A Karl; Shari M Piaskowski; Richard A Rudersdorf; Lyle T Wallace; Benjamin N Bimber; John T Loffredo; Daryl G Cox; Wilfried Bardet; William Hildebrand; Roger W Wiseman; Shelby L O'Connor; David H O'Connor
Journal:  J Virol       Date:  2009-04-01       Impact factor: 5.103

2.  Mhc haplotype H6 is associated with sustained control of SIVmac251 infection in Mauritian cynomolgus macaques.

Authors:  Edward T Mee; Neil Berry; Claire Ham; Ulrike Sauermann; Maria T Maggiorella; Frédéric Martinon; Ernst J Verschoor; Jonathan L Heeney; Roger Le Grand; Fausto Titti; Neil Almond; Nicola J Rose
Journal:  Immunogenetics       Date:  2009-04-01       Impact factor: 2.846

3.  Comprehensive identification of high-frequency and co-occurring Mafa-DPA1, Mafa-DQA1, Mafa-DRA, and Mafa-DOA alleles in Vietnamese cynomolgus macaques.

Authors:  Ruirui Xiang; Huiling Zhang; Qing Deng; Rui Yue; Haite Tang; Yanqi Zhang; Fei Ling; Min Zhuo; Hongli Du; Shiqian Xu; Qiang Xu; Xiaoning Wang
Journal:  Immunogenetics       Date:  2013-06-22       Impact factor: 2.846

4.  Influence of the MHC genotype on the progression of experimental SIV infection in the Mauritian cynomolgus macaque.

Authors:  Alice Aarnink; Nathalie Dereuddre-Bosquet; Bruno Vaslin; Roger Le Grand; Peter Winterton; Pol-André Apoil; Antoine Blancher
Journal:  Immunogenetics       Date:  2011-01-14       Impact factor: 2.846

5.  Diversity of TRIM5α and TRIMCyp sequences in cynomolgus macaques from different geographical origins.

Authors:  Neil J Berry; Flavia Marzetta; Greg J Towers; Nicola J Rose
Journal:  Immunogenetics       Date:  2011-11-29       Impact factor: 2.846

6.  MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques.

Authors:  Shelby L O'Connor; Jennifer J Lhost; Ericka A Becker; Ann M Detmer; Randall C Johnson; Caitlin E Macnair; Roger W Wiseman; Julie A Karl; Justin M Greene; Benjamin J Burwitz; Benjamin N Bimber; Simon M Lank; Jennifer J Tuscher; Edward T Mee; Nicola J Rose; Ronald C Desrosiers; Austin L Hughes; Thomas C Friedrich; Mary Carrington; David H O'Connor
Journal:  Sci Transl Med       Date:  2010-03-10       Impact factor: 17.956

7.  Identification of novel MHC class I sequences in pig-tailed macaques by amplicon pyrosequencing and full-length cDNA cloning and sequencing.

Authors:  Claire E O'Leary; Roger W Wiseman; Julie A Karl; Benjamin N Bimber; Simon M Lank; Jennifer J Tuscher; David H O'Connor
Journal:  Immunogenetics       Date:  2009-09-24       Impact factor: 2.846

8.  Lentiviral vector-based prime/boost vaccination against AIDS: pilot study shows protection against Simian immunodeficiency virus SIVmac251 challenge in macaques.

Authors:  Anne-Sophie Beignon; Karine Mollier; Christelle Liard; Frédéric Coutant; Sandie Munier; Julie Rivière; Philippe Souque; Pierre Charneau
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

9.  Study of cynomolgus monkey (Macaca fascicularis) DRA polymorphism in four populations.

Authors:  Alice Aarnink; Laurent Estrade; Pol-André Apoil; Yuki F Kita; Naruya Saitou; Takashi Shiina; Antoine Blancher
Journal:  Immunogenetics       Date:  2010-01-22       Impact factor: 2.846

10.  Characterization of 47 MHC class I sequences in Filipino cynomolgus macaques.

Authors:  Kevin J Campbell; Ann M Detmer; Julie A Karl; Roger W Wiseman; Alex J Blasky; Austin L Hughes; Benjamin N Bimber; Shelby L O'Connor; David H O'Connor
Journal:  Immunogenetics       Date:  2008-12-24       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.